Skip to content
Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data

Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data

  • Post published:May 5, 2021
  • Post category:Press Release
Read more about the article Mydecine Announces Partnership with LeadGen Labs

Mydecine Announces Partnership with LeadGen Labs

  • Post published:May 5, 2021
  • Post category:Press Release
Read more about the article MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics

MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics

  • Post published:May 5, 2021
  • Post category:Press Release
Read more about the article Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

  • Post published:May 4, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Acquires Vitamind Line of Wellness Products

Lobe Sciences Acquires Vitamind Line of Wellness Products

  • Post published:May 4, 2021
  • Post category:Press Release
Read more about the article Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers

Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers

  • Post published:May 4, 2021
  • Post category:Press Release
Read more about the article Psyched Wellness Signs Supply Agreement for Amanita Muscaria

Psyched Wellness Signs Supply Agreement for Amanita Muscaria

  • Post published:May 4, 2021
  • Post category:Press Release
Read more about the article Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

  • Post published:May 4, 2021
  • Post category:Press Release
Read more about the article Tryp Therapeutics Partners with Fluence for Psychotherapy Design

Tryp Therapeutics Partners with Fluence for Psychotherapy Design

  • Post published:May 3, 2021
  • Post category:Press Release
Read more about the article Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

  • Post published:May 3, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2026, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More